Clinical Trials
4 trialsNCT02518555 2026-04-06
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT04484532 2023-06-06
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT00964821 2017-11-07
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Completed
NCT00022035 2013-01-31
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
Phase NA Completed